This week Illinois became the primary state to shift the burden of paying for a potentially life-saving shot of an epinephrine injection for youngsters from parents to insurance companies.
Illinois Gov. JB Pritzker signed a law that might require companies offering insurance policies within the state to buy medically-necessary epinephrine injectors for cases of severe allergies for those 18 and younger. House Bill 3435 takes effect Jan. 1.
The Allergy and Asthma Network confirmed in an email to USA TODAY that Illinois is that the Delaware to need insurance companies buy injectors. Pritzker tweeted that …
The legislation is “a big breakthrough in protecting our youngsters and families.”
Parents can only hope Illinois is an example for other states as they struggled last year with finding EpiPens, far and away the most important the most important provider of the epinephrine injection system, and paying for them amid rising costs.
More:FDA approves first generic EpiPen in blow to Mylan
“As a parent whose kid needs an epipen (which “expires” every six months) at college , camp, and grandmas, this is often huge,” tweeted @mbenko23.
An epinephrine injector, used during an anaphylactic attack, delivers a dose of epinephrine, or adrenaline that minimizes swelling and opens airways.
Illinois senator Julie Morrison said no child should suffer because they can’t afford an EpiPen. the value of the EpiPen jumped from $57 in 2007 to about $500 in 2016.
“With steady increases in food allergies and other serious allergic conditions, families are counting on EpiPens quite ever before,” Morrison said during a statement. “We should be doing everything we will to expand access to affordable lifesaving drugs and medicines. No child with a significant allergy should be without an epinephrine injector because they can’t afford one.”